Novel therapeutic strategies and recent advances in gut microbiota synergy with nanotechnology for colorectal cancer treatment
Materials Today Bio · 2025-04 · 31 · 101601
DOI: 10.1016/j.mtbio.2025.101601 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Materials Today Bio, 2025-04. Verfasst von Qinghe Han und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, The Second Affiliated Hospital of Jilin University, Changchun, 130062, China. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 167 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, People's Government of Jilin Province.
Abstract (Originalsprache)
Over the last two decades, molecular biology advances have revealed the gut microbiota's active and crucial role in colorectal cancer (CRC) pathogenesis and its dysregulation during tumorigenesis. This understanding has underscored the urgency of exploring novel therapeutic approaches to address the challenges posed by CRC. Among these approaches, nanosynergistic therapies, with their potential to modulate the gut microbiota, increase drug bioavailability and stability, and reduce side effects, have emerged as a promising avenue. Furthermore, the efficacy of nanotechnology-based approaches can be enhanced by combining them with different therapeutic methods, including chemotherapy, radiotherapy, immunotherapy, photothermal therapy, and sonodynamic therapy. Herein, recent progress in nano synergistic therapy has been reviewed, focusing on the synergy between gut microbiota and nanotechnology in CRC treatment. Additionally, the diverse applications of nanoparticles have been analyzed to provide innovative ideas and effective solutions for developing highly effective CRC treatment strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, The Second Affiliated Hospital of Jilin University, Changchun, 130062, China.
- Department of Pharmacy, The Affiliated Hospital of Changchun University of Chinese Medicine, Changchun, 130021, China.
- Department of Radiotherapy, The Second Affiliated Hospital of Jilin University, Changchun, 130062, China.
Förderung
- National Natural Science Foundation of China
- People's Government of Jilin Province
Zitieren
APA
Han, Q., Li, J., Li, Z., Aishajiang, R., & Yu, D. (2025). Novel therapeutic strategies and recent advances in gut microbiota synergy with nanotechnology for colorectal cancer treatment. Materials Today Bio, 31, 101601. https://doi.org/10.1016/j.mtbio.2025.101601
Vancouver
Han Q, Li J, Li Z, Aishajiang R, Yu D. Novel therapeutic strategies and recent advances in gut microbiota synergy with nanotechnology for colorectal cancer treatment. Materials Today Bio. 2025;31:101601. doi:10.1016/j.mtbio.2025.101601
BibTeX
@article{Han2025,
author = {Han, Qinghe and Li, Jie and Li, Zhuo and Aishajiang, Reyida and Yu, Duo},
title = {Novel therapeutic strategies and recent advances in gut microbiota synergy with nanotechnology for colorectal cancer treatment},
journal = {Materials Today Bio},
year = {2025},
volume = {31},
pages = {101601},
doi = {10.1016/j.mtbio.2025.101601}
}
EUVIMED